These results suggest that elevating irisin production might be a compensatory mechanism that protects the liver against the onset of hepatocyte metabolic and oxidative stress and the development of NAFLD. This evidence concerns the gene FNDC5 and metabolic dysfunction-associated steatotic liver disease.